Evidence map›Paper›PMID 15834031›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2005

Homocysteine and related genetic polymorphisms in Down's syndrome IQ.

J-L Guéant, G Anello, P Bosco, R-M Guéant-Rodríguez, A Romano, C Barone, P Gérard, C Romano

Abstract read
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Thyroid hormone and folinic acid in young children with Down syndrome: the phase 3 ACTHYF trial.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Trial
  2. Trial
  3. Article
  4. Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Plasma amino acids and neopterin in healthy persons with Down's syndrome.Journal of neural transmission (Vienna, Austria : 1996) · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

J-L GuéantIRCCS, Oasi Maria SS-Institute for Research on Mental Retardation and Brain Aging, Troina (EN), Italy. Jean-Louis.Gueant@medecine.uhp-nancy.fr
G Anello
P Bosco
R-M Guéant-Rodríguez
A Romano
C Barone
P Gérard
C Romano

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDown's syndrome (DS) is the most frequent genetic cause of Alzheimer-type dementia. Its metabolic phenotype involves an increased trans-sulphuration of homocysteine. The aim of the present study was to investigate the influence of homocysteinaemia (t-Hcys), folate, vitamin B(12), and related polymorphisms on intelligence quotient (IQ) in DS.

methodsThe IQ of 131 patients with trisomy 21 from a specialist centre in Sicily was determined and classified according to DMS-IV. The effects of age, folate, vitamin B(12), t-Hcys, and genetic polymorphisms on IQ were evaluated separately and in combination using regression analyses.

resultsIQ was significantly lower in DS patients with t-Hcys >7.5 micromol/l (median) and in those who were carriers of methylenetetrahydrofolate reductase (MTHFR) 677 T allele and of methylenetetrahydrofolate reductase 677 T and transcobalamin 776 G combined alleles (p = 0.0013, p = 0.0165, and p = 0.0074, respectively). The IQ correlated significantly with t-Hcys and folate in single and multiple regression analyses, independently of age. In addition, t-Hcys >9.6 micromol/l (upper quartile) was found to be associated with low IQ (<40, median of study group) with an odds ratio of 2.61 (p = 0.0203). The odds ratio was increased by threefold in carriers of MTHFR 677T allele. The MTHFR 677T allele/transcobalamin 776 G allele combination was associated with the risk of DS patients to have an IQ less that the median with an odds ratio of 2.68 (95% CI 1.26 to 5.70, p = 0.0104).

conclusionThis study found evidence of an association between t-Hcys and MTHFR 677 T and transcobalamin 776 G alleles with IQ in patients with DS. The association may be related to a defective remethylation of homocysteine, affecting IQ.

Indexed as

AllelesAlzheimer DiseaseApolipoproteins EDiagnostic and Statistical Manual of Mental DisordersDown SyndromeFolic AcidHomocysteineHumansIntelligenceKaryotypingMethylenetetrahydrofolate Reductase (NADPH2)Polymorphism, GeneticTranscobalaminsVitamin B 12Apolipoproteins EFolic AcidHomocysteineMethylenetetrahydrofolate Reductase (NADPH2)TranscobalaminsVitamin B 12

Identifiers

PMID15834031
PMCPMC1739618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.